HealthEquity (NASDAQ:HQY) Price Target Cut to $94.00 by Analysts at The Goldman Sachs Group

HealthEquity (NASDAQ:HQY) had its target price cut by The Goldman Sachs Group from $107.00 to $94.00 in a report published on Thursday,Benzinga reports. They currently have a neutral rating on the stock.

Other research analysts have also recently issued reports about the stock. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. Wells Fargo & Company lifted their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. JMP Securities increased their price target on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. KeyCorp cut their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Monday. Finally, Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $120.00 to $115.00 in a research report on Tuesday. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $112.23.

HealthEquity Stock Performance

NASDAQ HQY opened at $88.83 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59. The firm has a market capitalization of $7.68 billion, a P/E ratio of 81.50, a P/E/G ratio of 1.60 and a beta of 0.62. The business’s 50-day simple moving average is $103.94 and its 200-day simple moving average is $95.84.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

Hedge funds and other institutional investors have recently bought and sold shares of the company. Holocene Advisors LP acquired a new stake in shares of HealthEquity during the third quarter worth $1,246,000. HighTower Advisors LLC raised its stake in HealthEquity by 4.8% during the fourth quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock worth $9,122,000 after acquiring an additional 4,370 shares during the period. Geneva Capital Management LLC raised its stake in HealthEquity by 24.6% during the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after acquiring an additional 206,894 shares during the period. BNP Paribas Financial Markets lifted its holdings in HealthEquity by 165.7% in the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock worth $1,673,000 after acquiring an additional 12,745 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company’s stock valued at $104,280,000 after acquiring an additional 25,004 shares during the period. 99.55% of the stock is owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.